Intelligent Cryogenic Tissue Remodeling System

Publication ID: 24-11857239_0010_PTD
Published: November 07, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Intelligent Cryogenic Tissue Remodeling System,” Published Technical Disclosure No. 24-11857239_0010_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857239_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,239.

Summary of the Inventive Concept

A next-generation cryogenic system that dynamically adjusts cryogenic temperatures based on real-time tissue response feedback, machine learning algorithms, and personalized treatment recommendations to optimize treatment outcomes for a wide range of cosmetic and medical applications.

Background and Problem Solved

The original cryogenic needle with freeze zone regulation patent (US [insert number]) had limitations in achieving optimal treatment outcomes due to its inability to adapt to individual skin characteristics and tissue response. The new inventive concept addresses this limitation by integrating advanced imaging techniques, machine learning algorithms, and real-time tissue response feedback to provide personalized and optimized treatment outcomes.

Detailed Description of the Inventive Concept

The Intelligent Cryogenic Tissue Remodeling System comprises a needle probe with a freeze zone regulation module that dynamically adjusts cryogenic temperatures based on real-time tissue response feedback. The module utilizes machine learning algorithms to predict optimal cryogenic temperatures for a specific treatment area and integrates with a patient database to provide personalized treatment recommendations based on individual skin characteristics. The system employs advanced imaging techniques to identify and target specific lesion structures for optimal treatment outcomes. The module regulates the coolant supply system to maintain the cooling zone within an allowable size tolerance, ensuring precise and controlled treatment.

Novelty and Inventive Step

The new claims introduce the concept of dynamic temperature adjustment based on real-time tissue response feedback, machine learning algorithms, and personalized treatment recommendations, which is not present in the original patent. This represents a significant paradigm shift in cryogenic tissue remodeling, enabling more accurate and effective treatment outcomes.

Alternative Embodiments and Variations

Alternative embodiments of the Intelligent Cryogenic Tissue Remodeling System could include variations in the type of imaging techniques used, the machine learning algorithms employed, and the integration with different patient databases or electronic health records systems. Additionally, the system could be adapted for use in various medical specialties, such as dermatology, oncology, or orthopedics.

Potential Commercial Applications and Market

The Intelligent Cryogenic Tissue Remodeling System has significant commercial potential in the medical aesthetics and cosmetic industries, as well as in various medical specialties. The system's ability to provide personalized and optimized treatment outcomes could revolutionize the treatment of skin lesions, cosmetic defects, and other medical conditions, offering a competitive advantage in the market.

CPC Classifications

SectionClassGroup
A A61 A61B18/02
A A61 A61B2017/00473
A A61 A61B2018/00029
A A61 A61B2018/00041
A A61 A61B2018/00648
A A61 A61B2018/00714
A A61 A61B2018/00738
A A61 A61B2018/00744
A A61 A61B2018/00779
A A61 A61B2018/00791
A A61 A61B2018/00898
A A61 A61B2018/00994
A A61 A61B2018/0262
A A61 A61B2018/0293

Original Patent Information

Patent NumberUS 11,857,239
TitleCryogenic needle with freeze zone regulation
Assignee(s)Pacira CryoTech, Inc.